After initial examination of 70 patients for eligibility, two patients were not confirmed to be eligible in the first stage, due to misdiagnosis of ALS, one of them had myasthenia gravis (MG) with anti-MUSK antibodies and the second patient had SMA (Spinal muscular atrophy) type 4. Here, SMN1 is linked to amyotrophic lateral sclerosis.